“High-Cost Drugs”

71 result(s)
Specialty
High-Touch, Whole Patient Care for PAH
PAH is a rare, life-threatening disease, which is incurable. It is difficult to manage and to help ensure the longest survival and best possible quality of life, members need... More
Briefing
Specialty
Three Major Challenges Facing Gene Therapy
The Top Challenges Facing Gene Therapy Today More
Briefing
Public Policy
RxSavingsPlus
RxSavingsPlus Provides Savings for Members without Pharmacy Benefits More
Video
Cost Management
Reducing Wasteful Spend on High-Cost, Low-Value Drugs
CVS Health’s Hyperinflation Strategy Helps Clients Reduce Unnecessary Drug Spend More
Briefing
Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and Approval Timelines
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines More
Briefing
Drug Pipeline
Treatment Options Expand in Robust Gene Therapy Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon More
Briefing
Drug Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline More
Briefing
Drug Pipeline
New Migraine Drugs Near Approval
... More
Briefing
Cost Management
2022 CVS Caremark Formulary Updates
2022 CVS Caremark Formulary Updates Deliver Exceptional Value and Cost Management More
Briefing
Cost Management
Assessing New-to-Market Biologics and Biosimilars
CVS Health offers strategies for addressing new-to-market products to ensure access to clinically appropriate insulin or other medications. More
Commentary